Edward J. Rapp - 30 Sep 2024 Form 4 Insider Report for AbbVie Inc. (ABBV)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ABBV	Stock Equivalent Units	Award	$32,387	+164	+0.62%	$197.48	26,544	30 Sep 2024	Common Stock	164	$197.48	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock.
F2	Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.